In an
interview with CNBC, Health Secretary Alex Azar revealed that the Trump administration is working on a plan that would allow the U.S. to import medicines from Canada, but offered no additional details as to how the plan would work.
The drugs industry will surely oppose the initiative.
ETFs:
BIB,
GRX,
THW,
BME,
BIS,
IXJ,
ARKG,
CHNA,
IDNA,
XLV,
XBI,
PJP,
IHE,
XPH
Selected tickers: Pfizer (
PFE -4.1%), Bristol-Myers Squibb (
BMY -0.2%), Merck (
MRK +2.5%), Eli Lilly (
LLY +0.9%), Johnson & Johnson (
JNJ -0.8%), Amgen (
AMGN -0.5%), Biogen (
BIIB +0.3%), Gilead Sciences (
GILD-0.7%), Roche (
OTCQX:RHHBY)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.